The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Feb 9, 2024 | Perry David P | Executive Chairman, Director, 10% Owner | Grant(A) | 840K | $0.19 | $160K |
| Jan 9, 2024 | Perry David P | Executive Chairman, Director, 10% Owner | Grant(A) | 1.5M | $0.17 | $250K |
| Dec 18, 2023 | Berman Mark A. | Chief Medical Officer | Grant(A) | 25K | — | $0 |
| Dec 18, 2023 | Karbe Frank | Chief Executive Officer, Director | Grant(A) | 63K | — | $0 |
| Dec 18, 2023 | Granger Elder | Director | Grant(A) | 4K | — | $0 |
| Dec 18, 2023 | Miller Leslie A. | Principal Accounting Officer | Grant(A) | 4K | — | $0 |
| Dec 18, 2023 | Armanino Andrew J. | Director | Grant(A) | 4K | — | $0 |
| Dec 18, 2023 | Parker Geoffrey M. | Director | Grant(A) | 4K | — | $0 |
| Dec 18, 2023 | Wynholds Kristin | Chief Product Officer | Grant(A) | 25K | — | $0 |
| Dec 18, 2023 | Lavizzo-Mourey Risa J | Director | Grant(A) | 4K | — | $0 |
| Dec 18, 2023 | Carmona Richard H | Director | Grant(A) | 4K | — | $0 |
| Dec 18, 2023 | Perry David P | Executive Chairman, Director, 10% Owner | Grant(A) | 4K | — | $0 |
| Jul 27, 2023 | Parker Geoffrey M. | Director | Buy(P) | 685K | $0.73 | $500K |
| Jul 27, 2023 | Karbe Frank | Chief Executive Officer, Director | Buy(P) | 137K | $0.73 | $100K |
| Jul 27, 2023 | Granger Elder | Director | Buy(P) | 34K | $0.73 | $25K |
| Jul 27, 2023 | Armanino Andrew J. | Director | Buy(P) | 274K | $0.73 | $200K |
| Jul 27, 2023 | Berman Mark A. | Chief Medical Officer | Buy(P) | 55K | $0.73 | $40K |
| Jul 27, 2023 | Perry David P | Executive Chairman, Director, 10% Owner | Buy(P) | 1.2M | $0.73 | $900K |
| Jun 7, 2023 | Perry David P | Executive Chairman, Director, 10% Owner | Grant(A) | 15K | — | $0 |
| Jun 7, 2023 | Parker Geoffrey M. | Director | Grant(A) | 15K | — | $0 |
| Jun 7, 2023 | Lavizzo-Mourey Risa J | Director | Grant(A) | 15K | — | $0 |
| Jun 7, 2023 | Armanino Andrew J. | Director | Grant(A) | 15K | — | $0 |
| Jun 7, 2023 | Granger Elder | Director | Grant(A) | 15K | — | $0 |
| Jun 7, 2023 | Carmona Richard H | Director | Grant(A) | 15K | — | $0 |
| May 16, 2023 | Granger Elder | Director | Buy(P) | 600 | $0.87 | $522 |
| Apr 10, 2023 | Armanino Andrew J. | Director | Buy(P) | 303K | $0.83 | $252K |
| Apr 10, 2023 | Parker Geoffrey M. | Director | Buy(P) | 303K | $0.83 | $252K |
| Apr 10, 2023 | Karbe Frank | See Remarks, Director | Buy(P) | 242K | $0.83 | $201K |
| Apr 10, 2023 | David P. Perry 2015 Trust | 10% Owner | Buy(P) | 3.6M | $0.83 | $3.0M |
| Apr 10, 2023 | David P. Perry 2015 Trust | 10% Owner | Buy(P) | 1.3M | $0.83 | $1.1M |
| Apr 5, 2023 | Berman Mark A. | Chief Medical Officer | Grant(A) | 101K | — | $0 |
| Apr 5, 2023 | Wynholds Kristin | Chief Product Officer | Grant(A) | 101K | — | $0 |
| Apr 5, 2023 | Heinen Mark | Chief Financial Officer | Grant(A) | 54K | — | $0 |
| Mar 1, 2023 | Berman Mark A. | Chief Medical Officer | Grant(A) | 101K | — | $0 |
| Mar 1, 2023 | Wynholds Kristin | Chief Product Officer | Grant(A) | 101K | — | $0 |
| Mar 1, 2023 | Heinen Mark | Chief Financial Officer | Grant(A) | 29K | — | $0 |
| Nov 30, 2022 | Heinen Mark | See Remarks | Grant(A) | 16K | $1.24 | $19K |
| Nov 30, 2022 | Wynholds Kristin | Chief Product Officer | Grant(A) | 4K | $1.24 | $5K |
| Sep 16, 2022 | David P. Perry 2015 Trust | 10% Owner | Buy(P) | 39K | $2.07 | $81K |
| Sep 15, 2022 | Karbe Frank | See Remarks, Director | Buy(P) | 50K | $2.09 | $105K |
| Sep 15, 2022 | David P. Perry 2015 Trust | 10% Owner | Buy(P) | 11K | $1.99 | $22K |
| Sep 13, 2022 | Heinen Mark | See Remarks | Buy(P) | 26K | $1.94 | $51K |
| Sep 12, 2022 | Heinen Mark | See Remarks | Buy(P) | 24K | $1.94 | $46K |
| Jul 5, 2022 | Karbe Frank | See Remarks, Director | Grant(A) | 472K | — | $0 |
| Jun 24, 2022 | Heinen Mark | See Remarks | Buy(P) | 2K | $1.75 | $4K |
| Jun 14, 2022 | Armanino Andrew J. | Director | Buy(P) | 15K | $1.39 | $21K |
| Jun 13, 2022 | Parker Geoffrey M. | Director | Buy(P) | 25K | $1.45 | $36K |
| Jun 10, 2022 | Heinen Mark | See Remarks | Buy(P) | 5K | $1.56 | $8K |
| Jun 9, 2022 | Perry David P | See Remarks, Director, 10% Owner | Grant(A) | 15K | — | $0 |
| Jun 9, 2022 | Armanino Andrew J. | Director | Buy(P) | 25K | $1.65 | $41K |
| Jun 9, 2022 | Armanino Andrew J. | Director | Grant(A) | 15K | — | $0 |
| Jun 9, 2022 | Carmona Richard H | Director | Grant(A) | 15K | — | $0 |
| Jun 9, 2022 | Lavizzo-Mourey Risa J | Director | Grant(A) | 15K | — | $0 |
| Jun 9, 2022 | Liu Suying | Director | Grant(A) | 15K | — | $0 |
| Jun 9, 2022 | Parker Geoffrey M. | Director | Grant(A) | 15K | — | $0 |
| Jun 9, 2022 | Granger Elder | Director | Grant(A) | 15K | — | $0 |
| May 31, 2022 | Wynholds Kristin | Chief Product Officer | Grant(A) | 5K | $1.54 | $8K |
| May 27, 2022 | Zamirowski Justin | Chief Commercial Officer | Option exercise(M) | 2K | $0.50 | $839 |
| May 27, 2022 | Zamirowski Justin | Chief Commercial Officer | Option exercise(M) | 2K | — | $0 |
| May 16, 2022 | Zamirowski Justin | Chief Commercial Officer | Option exercise(M) | 35K | $0.50 | $18K |
| May 16, 2022 | Zamirowski Justin | Chief Commercial Officer | Option exercise(M) | 35K | — | $0 |
| Apr 1, 2022 | Kevin Appelbaum, or his successor(s), as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020, as amended | 10% Owner | Grant(A) | 235K | — | $0 |
| Apr 1, 2022 | Heinen Mark | See Remarks | Grant(A) | 33K | — | $0 |
| Apr 1, 2022 | Berman Mark A. | Chief Medical Officer | Grant(A) | 117K | — | $0 |
| Apr 1, 2022 | Zamirowski Justin | Chief Commercial Officer | Grant(A) | 87K | — | $0 |
| Apr 1, 2022 | Wynholds Kristin | Chief Product Officer | Grant(A) | 117K | — | $0 |
| Mar 31, 2022 | Kevin Appelbaum, or his successor(s), as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020, as amended | 10% Owner | Buy(P) | 3K | $1.97 | $5K |
| Mar 31, 2022 | Heinen Mark | See Remarks | Buy(P) | 5K | $1.98 | $10K |
| Mar 29, 2022 | Parker Geoffrey M. | Director | Buy(P) | 15K | $2.15 | $32K |
| Mar 29, 2022 | Armanino Andrew J. | Director | Buy(P) | 40K | $2.14 | $86K |
| Dec 21, 2021 | Lavizzo-Mourey Risa J | Director | Buy(P) | 10K | $4.60 | $46K |
| Dec 20, 2021 | Kevin Appelbaum, or his successor(s), as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020, as amended | 10% Owner | Buy(P) | 1K | $4.60 | $5K |
| Dec 15, 2021 | Kevin Appelbaum, or his successor(s), as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020, as amended | 10% Owner | Buy(P) | 750 | $4.71 | $4K |
| Dec 15, 2021 | Heinen Mark | See Remarks | Buy(P) | 2K | $4.70 | $11K |
| Dec 14, 2021 | Parker Geoffrey M. | Director | Buy(P) | 20K | $4.94 | $99K |
| Dec 14, 2021 | Heinen Mark | See Remarks | Buy(P) | 500 | $5.44 | $3K |
| Dec 13, 2021 | Heinen Mark | See Remarks | Buy(P) | 500 | $5.45 | $3K |
| Dec 13, 2021 | Armanino Andrew J. | Director | Buy(P) | 21K | $5.48 | $115K |
| Dec 10, 2021 | Kevin Appelbaum, or his successor(s), as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020, as amended | 10% Owner | Buy(P) | 1K | $5.98 | $6K |
| Dec 3, 2021 | Granger Elder | Director | Buy(P) | 1K | $6.66 | $7K |
| Dec 3, 2021 | Kevin Appelbaum, or his successor(s), as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020, as amended | 10% Owner | Buy(P) | 500 | $6.43 | $3K |
| Dec 2, 2021 | Kevin Appelbaum, or his successor(s), as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020, as amended | 10% Owner | Buy(P) | 500 | $6.84 | $3K |
| Nov 29, 2021 | Armanino Andrew J. | Director | Buy(P) | 17K | $6.96 | $118K |
| Nov 10, 2021 | Granger Elder | Director | Grant(A) | 28K | — | $0 |
| Oct 28, 2021 | Carmona Richard H | Director | Grant(A) | 28K | — | $0 |
| Oct 28, 2021 | Carmona Richard H | Director | Grant(A) | 154K | — | — |
| Oct 28, 2021 | Liu Suying | Director | Grant(A) | 28K | — | $0 |
| Oct 28, 2021 | Liu Suying | Director | Other(J) | 143K | — | — |
| Oct 28, 2021 | Liu Suying | Director | Other(J) | 14K | — | — |
| Oct 28, 2021 | Liu Suying | Director | Other(J) | 1.4M | — | — |
| Oct 28, 2021 | Parker Geoffrey M. | Director | Grant(A) | 28K | — | $0 |
| Oct 28, 2021 | Parker Geoffrey M. | Director | Grant(A) | 33K | — | — |
| Oct 28, 2021 | Armanino Andrew J. | Director | Grant(A) | 28K | — | $0 |
| Oct 28, 2021 | Armanino Andrew J. | Director | Grant(A) | 48K | — | — |
| Oct 28, 2021 | Armanino Andrew J. | Director | Grant(A) | 13K | — | — |
| Oct 28, 2021 | David P. Perry 2015 Trust | 10% Owner | Grant(A) | 28K | — | $0 |
| Oct 28, 2021 | David P. Perry 2015 Trust | 10% Owner | Grant(A) | 100K | $10.00 | $1.0M |
| Oct 28, 2021 | David P. Perry 2015 Trust | 10% Owner | Buy(P) | 200K | $10.00 | $2.0M |
| Oct 28, 2021 | David P. Perry 2015 Trust | 10% Owner | Grant(A) | 21K | — | — |
| Oct 28, 2021 | David P. Perry 2015 Trust | 10% Owner | Grant(A) | 293K | — | — |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).